NCT00465959View on ClinicalTrials.gov

Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

trospium chloride inhalation powder (TrIP)

DRUG

Placebo

Trial Locations (1)

Unknown

United States Investigational Site, Spartanburg

Sponsors

Collaborators (1)

Alkermes, Inc.
All Listed Sponsors
collaborator

Alkermes, Inc.

INDUSTRY

lead

Endo Pharmaceuticals

INDUSTRY